ReWalk Robotics Ltd. (LFWD)
1.46
-0.10 (-6.41%)
At close: Jan 14, 2025, 3:59 PM
1.55
6.53%
After-hours Jan 14, 2025, 07:50 PM EST
undefined% (undefined)
| Bid | 1.46 |
| Market Cap | 15.46M |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | -2.23 |
| PE Ratio (ttm) | -0.65 |
| Forward PE | n/a |
| Analyst | Strong Buy |
| Ask | 1.6 |
| Volume | 389,811 |
| Avg. Volume (20D) | 235,422 |
| Open | 1.65 |
| Previous Close | 1.56 |
| Day's Range | 1.45 - 1.65 |
| 52-Week Range | 1.41 - 7.84 |
| Beta | undefined |
About LFWD
ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes robotic exoskeletons for individuals with mobility impairments or other medical conditions in the United States, Europe, the Asia-Pacific, and Africa. The company offers ReWalk Personal and ReWalk Rehabilitation for spinal cord injuries and everyday use by paraplegic individuals at home and in communities; ReStore, a soft exo-suit intended for use in the rehabil...
Industry Medical - Devices
Sector Healthcare
IPO Date Sep 12, 2014
Employees 108
Stock Exchange NASDAQ
Ticker Symbol LFWD
Website https://www.rewalk.com
Analyst Forecast
According to 2 analyst ratings, the average rating for LFWD stock is "Strong Buy." The 12-month stock price forecast is $13, which is an increase of 793.47% from the latest price.
Buy 50.00%
Hold 0.00%
Sell 0.00%
Next Earnings Release
ReWalk Robotics Ltd. is scheduled to release its earnings on Feb 25, 2025,
before market opens.
Analysts project revenue of $7.30M, reflecting a 6.04% YoY growth and earnings per share of -0.2, making a -42.86% decrease YoY.
Analysts project revenue of $7.30M, reflecting a 6.04% YoY growth and earnings per share of -0.2, making a -42.86% decrease YoY.
1 week ago ·
Source
-27.3%
Lifeward shares are trading lower after the compan...
Unlock content with
Pro Subscription
5 months ago ·
Source
+30.45%
ReWalk Robotics shares are trading higher. The company reported Q2 financial results.
